Abstracts (en)

  • 20. 05. 2019
  • Butsashvili M, Kamkamidze G, Metreveli D, Gamkrelidze  A, Zakalashvili M, Kerashvili V, Dolmazashvili E, Gamezardashvili A. Reversal of liver damage among HCV infected persons with advanced liver disease: Two-year follow-up from the HCV elimination program, Georgia.
    ASM Clinical virology symposium, May  2018,  West palm beach, Florida

  • G.Kamkamidze, M.Butsashvili, M.Kajaia, E.Pachkoria, G.Barbakadze, G.Kandelaki. Association of baseline viral load with sustained viral response among HCV infected patients treated with direct acting antivirals. ASM Clinical virology symposium. May 2018, West palm beach, Florida

  • Kamkamidze G, Butsashvili M, Kajaia M, Pachkoria E, Zarandia M. Association of Viral and Immunogenetic Factors with Sustained Viral Response among HCV Infected Patients Treated with Direct Acting Antivirals. The Asian Pacific Association for the Study of the Liver. April 2019, Tokyo, Japan

  • Chihota V, Japaridze M, Shilton S, Ruiz R, Francois Lamoury O’Brien J, Khonelidze I, Butsashvili M, Alkazashvili M, Marinucci F.  Approaches to providing hepatitis C viremia testing to people who inject drugs in Georgia. 4TH CEE Meeting on Viral Hepatitis and Co-Infection with HIV. October 2018, Prague, Czech Republic

  • Butsashvili M, Kamkamidze G, Kajaia M, Gulbiani L, Gamezardashvili A, Gvinjilia L, Kuchuloria T, Shadaker S, Nasrullah M. Attitude of staff regarding integrated hepatitis C treatment at eight harm reduction centers in Georgia. INHSU 2018. September 2018, Lisbon, Portugal

  • Kamkamidze G, Barbakadze G,Kajaia M , Pachkoria E, Butsashvili M. Association of age and mode of transmission with genotype distribution among hepatitis C virus infected patients in Georgia. ASM Clinical Virology Symposium. May 2018, Savannah, Georgia

  • Bouscaillou J, Kikvidze T, Le Pluart D , Butsashvili M, Labartkava K, Kamkamidze G, Inaridze I, Kharshiladze D, Avril E, Lacombe K, Boyd A, Luhmann N. Low HCV reinfection rate after treatment in people who infect drugs (PWID) from a prospective cohort in Tbilisi, Georgia. 7th International Symposium on Hepatitis Care in Substance Users. September 2018, Cascais, Portugal

  • Gulbiani L, Butsashvili M, Kajaia M, Kochlamazashvili M, Abzianidze T, Pachkoria E, Gamezardashvili A, Kamkamidze G. Characteristics of patients with missing sustained virologic response (SVR) data, elimination program in Georgia. International Viral Hepatitis Elimination Meeting (IVHEM) 2018. November 2018, Amsterdam, Netherlands

  • Long-term health outcome among HCV patients with advanced liver fibrosis treated through HCV elimination program in Georgia. PASCV 2018. May 2018, Savannah, Georgia

  • HCV treatment outcome among HCV/HBV co-infected patients.

  • HCV genotype diversity among patients treated with antiviral medications in Georgia.

  • HCV treatment outcome among patients attending opioid substation therapy clinics.